Dylan Shea

As a graduate student in Valerie Daggett’s lab, Dylan studied the molecular events that occur in the earliest stages of Alzheimer’s disease. He focused on the structural transitions of proteins associated with the Alzheimer’s brain to inform the development of diagnostic tests and therapeutics. After graduating in 2020, Dylan began working as a Principal Scientist at AltPep, a Daggett lab spinout that is developing early diagnostics, modifying therapeutics and anti-biofilm treatments for amyloid diseases.